SCHEMBL5222748

SCHEMBL5222748

Cc1ccn2cc(CNCc3ccc(-c4ccc(-c5noc(C)n5)cc4)cc3)nc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.48
HPGD P15428 3/20 0.48
TSHR P16473 2/20 0.48
GAA P10253 1/20 0.48
ALDH1A1 P00352 7/20 0.45
POLB P06746 3/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TP53 P04637 2/20 0.44
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
METTL3 Q86U44 2/20 0.41
HTT P42858 2/20 0.41
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HSD17B10 Q99714 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TPH1 P17752 1/20 0.40
TPH2 Q8IWU9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5225829 0.86 HDAC1 (0.47) KDM4EALDH1A1TP53HDAC1HDAC8
SCHEMBL5222368 0.78 RAB9A (0.45) KDM4EGAAALDH1A1POLBTDP1
SCHEMBL5222506 0.71 L3MBTL1 (0.43) ALDH1A1POLBL3MBTL1HDAC1HDAC8
SCHEMBL632081 0.69 PLK1 (0.56) HPGDTSHRALDH1A1L3MBTL1TP53
SCHEMBL5222143 0.68 HDAC1 (0.48) HPGDTSHRL3MBTL1HDAC1HDAC8
SCHEMBL5226935 0.68 LMNA (0.41) KDM4EL3MBTL1HDAC1HDAC8MAPT
SCHEMBL5225416 0.67 L3MBTL1 (0.43) TSHRALDH1A1L3MBTL1HDAC1HDAC8
SCHEMBL5224631 0.67 PLK1 (0.43) HPGDTSHRL3MBTL1HDAC1HDAC8
SCHEMBL21702520 0.67 PLK1 (0.51) HPGDTSHRL3MBTL1HDAC1HDAC8
SCHEMBL21683299 0.67 PLK1 (0.58) HPGDTSHRPOLBHDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060019998-A1 Histamine-3 receptor antagonist PFIZER INC 2006-01-26 US claimed
EP-1771449-A1 HISTAMINE-3 RECEPTOR ANTAGONISTS Pfizer Products Incorporated (US) 2007-04-11 EP disclosed
WO-2006011043-A1 HISTAMINE-3 RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2006-02-02 WO disclosed
US-20060019998-A1 Histamine-3 receptor antagonist PFIZER INC 2006-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060019998-A1 Histamine-3 receptor antagonist HRH3, HRH4, HRH2 KDM4E 3277/4885HPGD 1236/4885TSHR 432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.